| The JAK2 V617F mutation identifies a subgroup of MDS patients with isolated deletion 5q and a proliferative bone marrow W Ingram, NC Lea, J Cervera, U Germing, P Fenaux, B Cassinat, ... Leukemia 20 (7), 1319-1321, 2006 | 135 | 2006 |
| Dysregulated iron metabolism in polycythemia vera: etiology and consequences YZ Ginzburg, M Feola, E Zimran, J Varkonyi, T Ganz, R Hoffman Leukemia 32 (10), 2105-2116, 2018 | 98 | 2018 |
| Type 2 diabetes-related variants influence the risk of developing multiple myeloma: results from the IMMEnSE consortium R Ríos, CB Lupiañez, D Campa, A Martino, J Martínez-López, ... Endocrine-related cancer 22 (4), 545-559, 2015 | 98 | 2015 |
| Gaucher disease associated with parkinsonism: four further case reports J Várkonyi, H Rosenbaum, N Baumann, JJ MacKenzie, Z Simon, ... American journal of medical genetics Part A 116 (4), 348-351, 2003 | 73 | 2003 |
| Standards and impact of hematopathology in myelodysplastic syndromes (MDS) P Valent, A Orazi, G Büsche, A Schmitt-Gräff, TI George, K Sotlar, ... Oncotarget 1 (7), 483, 2010 | 70 | 2010 |
| Inappropriate Notch activity and limited mesenchymal stem cell plasticity in the bone marrow of patients with myelodysplastic syndromes G Varga, J Kiss, J Várkonyi, V Vas, P Farkas, K Pálóczi, F Uher Pathology & Oncology Research 13, 311-319, 2007 | 69 | 2007 |
| High incidence of hemochromatosis gene mutations in the myelodysplastic syndrome: the Budapest Study on 50 patients J Várkonyi, G Tarkovács, I Karádi, H Andrikovics, F Varga, F Varga, ... Acta haematologica 109 (2), 64-67, 2003 | 56 | 2003 |
| The data registry of the European Competence Network on Mastocytosis (ECNM): set up, projects, and perspectives P Valent, JNGO Elberink, A Gorska, M Lange, R Zanotti, B van Anrooij, ... The Journal of Allergy and Clinical Immunology: In Practice 7 (1), 81-87, 2019 | 52 | 2019 |
| Polymorphisms of TNF-alpha and LT-alpha genes in multiple myeloma K Kádár, M Kovács, I Karádi, B Melegh, Z Pocsai, G Mikala, A Tordai, ... Leukemia research 32 (10), 1499-1504, 2008 | 44 | 2008 |
| Prognostic impact of eosinophils in mastocytosis: analysis of 2350 patients collected in the ECNM Registry HC Kluin-Nelemans, A Reiter, A Illerhaus, B van Anrooij, K Hartmann, ... Leukemia 34 (4), 1090-1101, 2020 | 43 | 2020 |
| Exome sequencing identifies germline variants in DIS3 in familial multiple myeloma M Pertesi, M Vallée, X Wei, MV Revuelta, P Galia, D Demangel, J Oliver, ... Leukemia 33 (9), 2324-2330, 2019 | 42 | 2019 |
| European Competence Network on Mastocytosis (ECNM): 10-year jubilee, update, and future perspectives. P Valent, M Arock, P Bonadonna, K Brockow, S Broesby-Olsen, ... Wiener klinische Wochenschrift 124, 2012 | 41 | 2012 |
| Risk of multiple myeloma is associated with polymorphisms within telomerase genes and telomere length D Campa, A Martino, J Varkonyi, F Lesueur, K Jamroziak, S Landi, ... International journal of cancer 136 (5), E351-E358, 2015 | 39 | 2015 |
| Biochemical polymorphisms in goats with special reference to the Hungarian Native breed L Fésüs, J Varkonyi, Á Áts Animal Blood Groups and Biochemical Genetics 14 (1), 1-6, 1983 | 39 | 1983 |
| JAK2 46/1 haplotype analysis in myeloproliferative neoplasms and acute myeloid leukemia H Andrikovics, S Nahajevszky, M Koszarska, N Meggyesi, A Bors, G Halm, ... Leukemia 24 (10), 1809-1813, 2010 | 37 | 2010 |
| Refined diagnostic criteria for bone marrow mastocytosis: a proposal of the European competence network on mastocytosis R Zanotti, M Bonifacio, G Lucchini, WR Sperr, L Scaffidi, B van Anrooij, ... Leukemia 36 (2), 516-524, 2022 | 32 | 2022 |
| Quantitative assessment of JAK2 V617F and CALR mutations in Philadelphia negative myeloproliferative neoplasms A Gángó, R Mózes, Z Boha, B Kajtár, B Timár, PA Király, R Kiss, V Fésüs, ... Leukemia Research 65, 42-48, 2018 | 32 | 2018 |
| Activity of the notch‐signalling pathway in circulating human chronic lymphocytic leukaemia cells M Hajdu, A Sebestyén, G Barna, L Reiniger, J Jánosi, L Sréter, J Varkonyi, ... Scandinavian journal of immunology 65 (3), 271-275, 2007 | 29 | 2007 |
| The relationship between sister chromatid exchange induction and leukemogenicity of different cytostatics. T Raposa, J Várkonyi Cancer detection and prevention 10 (1-2), 141-151, 1987 | 29 | 1987 |
| Impact of polymorphic variation at 7p15. 3, 3p22. 1 and 2p23. 3 loci on risk of multiple myeloma A Martino, D Campa, K Jamroziak, RM Reis, J Sainz, G Buda, ... British journal of haematology 158 (6), 805-809, 2012 | 28 | 2012 |
